FDA Approves Ustekinumab Biosimilar to Stelara for Treatment of Plaque Psoriasis
Ustekinumab (Stelara; Janssen Immunology) is a human monoclonal antibody that treats immune-mediated diseases such as psoriasis and psoriatic arthritis.
Ustekinumab (Stelara; Janssen Immunology) is a human monoclonal antibody that treats immune-mediated diseases such as psoriasis and psoriatic arthritis.
AHRQ advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.
Use of digital healthcare technologies – for clinicians and patients – is growing. To ensure these solutions benefit all patient groups, creators and users must be…
This webcast discussed Indiana Hospital Association’s experiences using the Surveys on Patient Safety Culture® (SOPS®) Hospital Survey and Workplace Safety Item Set. They shared their…
Telemedicine use remains substantially higher than it was before the COVID-19 pandemic, although it has fallen from pandemic highs. To inform the ongoing debate about…
Pharmacists can help patients distinguish between food allergies and intolerances, as well as facilitate access to life-saving medications and preventative care.
NCQA’s Data Aggregator Validation program evaluates clinical data streams to help ensure the accuracy of aggregated clinical data for use in HEDIS® reporting.
Bridging between governmental, public health, and community power-building organizations is necessary to return public health to its roots in social change.
Tisotumab vedotin-tftv is the first antibody-drug conjugate to demonstrate positive overall survival data in patients with previously treated recurrent or metastatic cancer.
The Agency for Healthcare Research and Quality (AHRQ) Making Healthcare Safer (MHS) reports consolidate information for healthcare providers, health system administrators, researchers, and government agencies…